Evald Høj Christiansen
Evald Høj Christiansen is an expert in Cardiology at Aarhus University Hospital (Denmark). As of October 2026, ScienceLeadR ranks Evald Høj Christiansen in the top 1% of experts worldwide for Coronary Disease, Angina Pectoris and Myocardial Ischemia. Evald Høj Christiansen has authored 592 publications, the most recent in 2026, and is an investigator in 79 clinical trials, 5 of them ongoing. SLR score: 2,598 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Medical Imaging - Surgery - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1993 - 2026
Number : 592
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Impact of calcium burden, lesion preparation, and lithotripsy on stent underexpansion in severely calcified coronary lesions - a substudy of the BALI trial. PMID 42777787 — stents, constriction, pathologic, cardiology, calcium, tomography, optical coherence, wounds and injuries, lithotripsy | Int J Cardiol | 2026 | 0 |
| Safety and Effectiveness of a Novel Laser-Based Intravascular Lithotripsy System for Coronary Calcium: FRACTURE Study. PMID 42933913 — stents, safety, coronary artery disease, percutaneous coronary intervention, lasers, calcium, tomography, optical coherence, wounds and injuries, lithotripsy | JACC Cardiovasc Interv | 2026 | 0 |
| Corrigendum to "Impact of evolocumab on coronary physiology and microstructure in de-novo heart transplant recipients" [J Heart Lung Transplant 45 (2026) 26-36]. PMID 42925292 — physiology, lung, heart, heart transplantation, transplants, lung transplantation | J Heart Lung Transplant | 2026 | 0 |
| Unprotected Left Main Disease: Clinical Outcomes Following Deferral, Coronary Artery Bypass Grafting, or Percutaneous Coronary Intervention. PMID 42765913 — constriction, pathologic, mortality, stroke, percutaneous coronary intervention, cardiac catheterization, arteries, coronary artery bypass, therapeutics | Catheter Cardiovasc Interv | 2026 | 0 |
| Transcatheter aortic valve implantation in patients with tricuspid, bicuspid and bioprosthetic valves: observations from COMPARE-TAVI 1. PMID 42757819 — aortic valve stenosis, mitral valve, bioprosthesis, tricuspid valve, aortic valve, transcatheter aortic valve replacement, therapeutics, bicuspid | Scand Cardiovasc J | 2026 | 0 |
Clinical Studies 79
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 1
Ongoing Clinical Trials
5 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Optical Coherence Tomography in Acute Vessel Evaluation NCT07422688 — myocardial ischemia, heart diseases, coronary artery disease, tomography, heart, percutaneous coronary intervention, acute coronary syndrome, angiography, arteries, tomography, optical coherence, ischemia | N/A | Enrolling by invitation | 2025 |
| Comparison of an Ultra low Strut Thickness Everolimus eluting Biodegradable Polymer Stent Versus Durable Polymer Everolimus eluting Stents in Patients Treated With Percutaneous Coronary Intervention NCT06692140 — myocardial ischemia, stents, drug-eluting stents, polymers, coronary artery disease, pharmaceutical preparations, percutaneous coronary intervention, arteries, everolimus, ischemia | N/A | Recruiting | 2024 |
| Comparison of Evolut FX Versus Sapien 3 Ultra Resilia NCT06470022 — constriction, pathologic, aortic valve stenosis, aortic valve, transcatheter aortic valve replacement | N/A | Active not recruiting | 2024 |
| Modification of Coronary Calcium With Laser Based Intravascular Lithotripsy for Coronary Artery Disease (FRACTURE) NCT06181240 — coronary artery disease, percutaneous coronary intervention, arteries, lasers, calcium, wounds and injuries, lithotripsy | N/A | Active not recruiting | 2024 |
| INSIGHTFUL FFR Clinical Trial NCT05437900 — coronary artery disease, clinical decision-making, percutaneous coronary intervention, decision making, acute coronary syndrome, arteries, therapeutics | Phase 4 | Recruiting | 2022 |
LeadR Networks
Main global connection map